Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.March 10, 2026
‘I am stuck in a low-income trap’: I’m a teacher and very good at my job. Will I ever earn six figures?March 9, 2026
Stocks Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.By AdminMarch 10, 2026 Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both…
